Over the last 30 years, evidence has been gathered suggesting that merozoite surface
protein 1 (MSP1) is a target of protective immunity against malaria. In a variety of …

Naturally acquired immunity to malaria requires repeat infections yet does not engender
sterile immunity or long‐lasting protective immunologic memory. This renders infants and …

Vaccine development against the blood-stage malaria parasite is aimed at reducing the
pathology of the disease. We constructed a recombinant Mycobacterium bovis bacille …

Abstract Background The 19-kDa C-terminal region of the merozoite surface protein-1 of the
human malaria parasite Plasmodium falciparum (Pf MSP-1 19) constitutes the major …

The simple and less expensive technique based on magnetic nanoparticles (MNPs) was
developed for separation of malaria parasites containing specific antigens. The carboxylated …

Abstract Like Thomas Hardy's famous novel Far from the Madding Crowd, Plasmodium
falciparum parasites display their most relevant survival structures (proteins) involved in host …

Background The absence of antibodies specific for the 19 kDa C-terminal domain of
merozoite surface protein 1 (MSP1 19) has been associated with high-density malaria …

Background MSP1 processing-inhibitory antibodies bind to epitopes on the 19 kDa C-
terminal region of the Plasmodium falciparum merozoite surface protein 1 (MSP1 19) …

Although great efforts have been undertaken for the development of malaria vaccines, no
completely effective malaria vaccines are available yet. Despite being clinically silent, the …

La chimioprévention du paludisme saisonnier (CPS) est une nouvelle stratégie visant à
réduire la charge de morbidité du paludisme chez les jeunes enfants dans les pays …